New research reveals that individuals who come off blockbuster slimming jabs like Mounjaro or Wegovy may regain reduced body mass far faster than those who halt conventional lifestyle plans.
Research printed in a leading health publication points out that while obese people often shed substantial amounts of their total mass while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"People purchasing these drugs must be cognizant of the potential of quick rebound weight gain when the therapy concludes," stated expert Dr. Susan Jebb.
This pace of recovery suggests a reversion to original mass within about one and a half years.
Weighing Treatments
The research, which examined dozens of studies involving over 9,000 of participants, contrasted the results of the injectable medications with other pills.
Researchers point out that people who shed pounds through dieting typically experience a less rapid creep back—approximately 100 grams monthly—once they finish.
The Reason for the Fast Rebound
Nutrition scientists propose the mode of action of the jabs accounts for the heightened regain.
GLP-1 drugs imitate a body's own chemical called GLP-1, which moderates hunger.
"Sustained high doses of GLP-1 levels far above than normal might result in the body to produce less of its endogenous hormone, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Stopping of this hormone supplement leads to hunger is uncontrolled, making excessive eating much more probable."
A Lifelong Condition?
Medical guidelines advise the jabs for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians contend that, due to the significant potential of relapse, the treatment is often life-long.
This perspective is echoed by drug manufacturers, who state that the findings "underscore the long-term nature of obesity," akin to managing diseases like high blood pressure.
User Testimonies
People who have stopped the medication explain a powerful return of cravings.
"I experienced a trigger activating and you're instantly ravenous," described an individual.
This challenge is exacerbated if individuals have not adopted sustainable dietary or behavioural modifications during therapy.
Widespread Use
Survey data show that millions of people in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.
- Adoption is more common among women than males.
- The 40s and 50s age group shows the greatest usage rates.
- Many access the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while these medications are potent agents for weight loss, they are not a standalone fix and long-term success likely depends on integrated lifestyle support.
